Skip to main content

Table 3 Symptoms on VAS in the patient group and the control group

From: Quality of life and symptoms before and after nasal septoplasty compared with healthy individuals

Symptoms

Mean Preoperatively VAS (SD )

Mean Postoperatively VAS (SD )

P-value1

Control group

P-value2

Nasal blockage

71(SD20)

29(SD26)

0.000

9 (11)

0.000

Headache

33(SD30)

18(SD25)

0.000

16 (20)

0.5

Facial pain

16(SD24)

7(SD14)

0.000

9 (17)

0.4

Altered sense of smell

31(SD32)

12(SD24)

0.000

5 (9)

0.009

Nasal discharge

42(SD32)

22(SD29)

0.000

11 (19)

0.003

Sneezing

32(SD28)

17(SD23)

0.000

14 (15)

0.3

Trouble with rhinosinusitis

16(SD28)

4(SD12)

0.000

3 ( 7)

0.9

Cough

22(SD27)

9(SD17)

0.000

7 ( 9)

0.3

Snoring

54(SD33)

26(SD26)

0.000

26 (29)

0.8

Oral breathing

63(SD30)

23(SD27)

0.000

13 (22)

0.01

Reduced general health

47(SD31)

12(SD20)

0.000

5 ( 6)

0.007

  1. P-value1 is the p-value for improvement from preoperatively to postoperatively. P-value 2 is the p-value for a difference in postoperative symptoms in the patients compared to the controls